Glaukos Corporation: Glaucoma trials

The registry lists 22 Glaucoma studies with Glaukos Corporation as lead sponsor. 5 are open to participants now and 2 have results posted.

Phase 2 1Phase 3 4Phase 4 8No phase 9(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• iDose TR Administration in an Office-Based Surgery SettingRecruitingNCT07816692
• Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral ImplantRecruitingNCT07495852Phase 3
• Observational Trial of the Updated Inserter for the Travoprost Intracameral Implant 75mcgRecruitingNCT07400926
• Phase 2 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral ImplantRecruitingNCT07075718Phase 2
• Glaukos® iStent Infinite Trabecular Micro-Bypass System in Subjects With Mild to Moderate Primary Open-angle GlaucomaRecruitingNCT06057051Not applicable
• Safety and Efficacy of the GTS400 Stent in Conjunction With CataractCompletedNCT00721968Phase 3Results posted
• A Study of the Trabecular Micro-bypass Stent in Combination With Cataract Surgery in Subjects With Open Angle GlaucomaCompletedNCT00323284Phase 3Results posted
• Clinical Study of Glaukos® Trabecular Micro-Bypass System Model iS3 Infinite Vs. CompetitorActive, not recruitingNCT05127551Not applicable
• iStent Inject New Enrollment Post-Approval StudyActive, not recruitingNCT04624698Not applicable
• Investigation of the Glaukos® Trabecular Micro-Bypass System, Model iS3, in Subjects With Refractory GlaucomaStatus unknownNCT03639870Not applicable
• One, Two, or Three iStents for the Reduction of Intraocular Pressure in Open-angle Glaucoma SubjectsCompletedNCT01517477Not applicable
• A Prospective Evaluation of Open-Angle Glaucoma Subjects on Two Topical Hypotensive Medications Treated With One Suprachoroidal StentCompletedNCT01252914Phase 4
• Prospective Evaluation of Open-angle Glaucoma Subjects on Two Topical Hypotensive Medication Treated With Two iStentsCompletedNCT01252888Phase 4
• Prospective Evaluation of Open-Angle Glaucoma Subjects on One Topical Hypotensive Medication Treated With Two iStentsCompletedNCT01252862Phase 4
• Purpose of This Study is to Evaluate the Safety and Efficacy of One, Two, or Three iStents for the Reduction of Intraocular Pressure in Open-angle Glaucoma SubjectsCompletedNCT01252849Not applicable
• GTS400 Stent Implantation in Conjunction With Cataract Surgery in Subjects With Open-angle GlaucomaCompletedNCT01052558Phase 3
• Evaluation of the iStent Versus Two Ocular Hypotensive Agents in Patients With Primary Open-angle Glaucoma (POAG)CompletedNCT00913029Phase 4
• A Prospective, Unmasked Evaluation of the iStent in Patients With Primary Open-Angle GlaucomaCompletedNCT00911924Phase 4
• A Study of the Glaukos Trabecular Micro-bypass Stent in Open Angle Glaucoma Subjects 1 Stent Versus 2Status unknownNCT00326079Phase 4
• A Study of the iStent in Combo With Cataract Surgery in Newly Diagnosed Open Angle Glaucoma or OH Patients.CompletedNCT00326066Not applicable
• A Study of the Glaukos Trabecular Micro-Bypass Stent in Refractory Open Angle Glaucoma SubjectsCompletedNCT00326040Phase 4
• A Study of the Trabecular Micro-Bypass Stent in Combination With Cataract Surgery in Open Angle Glaucoma Subjects.CompletedNCT00326014Phase 4